Welsh, Eric

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

Scott, J. G., Berglund, A., Schell, M. J., Mihaylov, I., Fulp, W. J., Yue, B., Welsh, E., Caudell, J. J., Ahmed, K., Strom, T. S., et al. (2017) · The Lancet Oncology

Breast Cancer Treatment StudiesAdvanced Radiotherapy Techniques

Cited by 474

Cell Type–Specific Adaptive Signaling Responses to KRASG12C Inhibition

Solanki, H. S., Welsh, E. A., Fang, B., Izumi, V., Darville, L., Stone, B., Franzese, R., Chavan, S., Kinose, F., Imbody, D., et al. (2021) · Clinical Cancer Research

Protein Kinase Regulation and GTPase SignalingLung Cancer Treatments and Mutations

Cited by 106

Novel Metabolic Attributes of the Genus Cyanothece , Comprising a Group of Unicellular Nitrogen-Fixing Cyanobacteria

Bandyopadhyay, A., Elvitigala, T., Welsh, E., Stöckel, J., Liberton, M., Min, H., Sherman, L. A., & Pakrasi, H. B. (2011) · mBio

Metalloenzymes and iron-sulfur proteinsPhotosynthetic Processes and Mechanisms

Cited by 102

Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma

Mostofa, A., Distler, A., Meads, M. B., Sahakian, E., Powers, J. J., Achille, A., Noyes, D., Wright, G., Fang, B., Izumi, V., et al. (2021) · JCI Insight

Multiple Myeloma Research and TreatmentsHistone Deacetylase Inhibitors Research

Cited by 27